Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 271Breast Neoplasms 264Lung Neoplasms 130Prostatic Neoplasms 114Colorectal Neoplasms 108Carcinoma, Non-Small-Cell Lung 103Pancreatic Neoplasms 67Carcinoma, Hepatocellular 53Ovarian Neoplasms 51Stomach Neoplasms 49Multiple Myeloma 49Hematologic Neoplasms 49Urinary Bladder Neoplasms 47Brain Neoplasms 45Melanoma 42Leukemia, Myeloid, Acute 42Head and Neck Neoplasms 40Esophageal Neoplasms 40Colonic Neoplasms 38Disease 37Liver Neoplasms 36Precursor Cell Lymphoblastic Leukemia-Lymphoma 35Rectal Neoplasms 34Lymphoma 32Neoplasm Metastasis 31Leukemia, Lymphocytic, Chronic, B-Cell 30Endometrial Neoplasms 30Recurrence 28Kidney Neoplasms 28Uterine Cervical Neoplasms 27

Interventions

Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Hepatitis × 90 days × Clear all
NCT02908048 2026-05-05

Extracellular RNA Markers of Liver Disease and Cancer

Mayo Clinic

Terminated
1,865 enrolled
Gastrointestinal

Bile Duct Neoplasms, Biliary Tract Neoplasms, Fibrosis, Hepatitis, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡